Fernando Fervenza, MD
Mayo Clinic, Rochester, MN · Mayo Clinic
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Fernando Fervenza, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06676579 · Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)Mayo Clinic · recruiting · IgA Nephropathy (IgAN) · principal investigator
- Ph2NCT06295770 · Obinutuzumab in Treatment of Fibrillary GlomerulonephritisMayo Clinic · recruiting · Fibrillary Glomerulonephritis · principal investigator
- Ph2NCT05654506 · Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune DepositsMayo Clinic · active not recruiting · Proliferative Glomerulonephritis With Monoclonal IgG Deposits · principal investigator
- Ph2NCT04983888 · Obinutuzumab in Primary FSGSMayo Clinic · completed · Primary Focal Segmental Glomerulosclerosis · principal investigator
- Ph2NCT04868838 · Daratumumab to Treat Active Lupus NephritisMayo Clinic · active not recruiting · Lupus Nephritis · principal investigator
- Ph3NCT02282930 · Pilot Study of ACTH in the Treatment of Immunoglobulin A (IgA) Nephropathy at High Risk of ProgressionMayo Clinic · completed · Progressive IgA Nephropathy, Proteinuria · principal investigator
- N/ANCT01093781 · Aliskiren in Patients With Idiopathic Membranous NephropathyMayo Clinic · withdrawn · Idiopathic Membranous Nephropathy · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.